Tranzyme Pharma to Present at Biotechnology Industry Organization (BIO) CEO & Investor Conference

RESEARCH TRIANGLE PARK, N.C., Feb. 7, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Vipin K. Garg, Ph.D., President and CEO, will present at the BIO CEO & Investor Conference taking place at the Waldorf Astoria in New York, NY February 13-14, 2012. Tranzyme’s presentation is scheduled for Monday, February 13th at 4:00 pm ET in the Conrad Room.

MORE ON THIS TOPIC